Association of the Systemic Immune-Inflammation Index with Outcomes in Acute Coronary Syndrome Patients with Chronic Kidney Disease

References

• Fox CS, Muntner P, Chen AY, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation. 2010;121(3):357–365. doi:10.1161/CIRCULATIONAHA.109.865352
   PubMed Web of Science ®Google Scholar
• Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. doi:10.1161/CIRCULATIONAHA.120.050686
   PubMed Web of Science ®Google Scholar
• Tanik VO, Cinar T, Arugaslan E, et al. The predictive value of PRECISE-DAPT score for in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2019;70(5):440–447. doi:10.1177/0003319718807057
   PubMed Web of Science ®Google Scholar
• Hayiroglu MI, Keskin M, Uzun AO, et al. Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging. 2018;34(3):329–336. doi:10.1007/s10554-017-1241-9
   PubMed Web of Science ®Google Scholar
• Cinar T, Hayiroglu MI, Seker M, et al. The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock. Coron Artery Dis. 2019;30(8):569–574. doi:10.1097/MCA.0000000000000776
   PubMed Web of Science ®Google Scholar
• Weissberg PL, Bennett MR. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(24):1928–1929.
   PubMed Web of Science ®Google Scholar
• Amdur RL, Feldman HI, Dominic EA, et al. Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study. Am J Kidney Dis. 2019;73(3):344–353. doi:10.1053/j.ajkd.2018.09.012
   PubMed Web of Science ®Google Scholar
• Ebert T, Pawelzik SC, Witasp A, et al. Inflammation and premature ageing in chronic kidney disease. Toxins. 2020;12:4. doi:10.3390/toxins12040227
   Google Scholar
• Ridker PM, MacFadyen JG, Glynn RJ, et al. Inhibition of interleukin-1beta by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol. 2018;71(21):2405–2414. doi:10.1016/j.jacc.2018.03.490
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Oh TJ, Ahn CH, Kim BR, et al. Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus. Cardiovasc Diabetol. 2017;16(1):92. doi:10.1186/s12933-017-0568-9
   PubMedGoogle Scholar
• Yu P, Zhao J, Jiang H, et al. Neural cell adhesion molecule-1 may be a new biomarker of coronary artery disease. Int J Cardiol. 2018;257:238–242. doi:10.1016/j.ijcard.2017.12.040
   PubMedGoogle Scholar
• Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896–903. doi:10.1093/eurheartj/ehaa1034
   PubMed Web of Science ®Google Scholar
• Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol. 2014;114(7):972–978. doi:10.1016/j.amjcard.2014.07.005
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295–3302. doi:10.7150/jca.25691
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin S, Yang X, Wang R, Luo L. Prognostic value of pretreatment systemic immune-inflammation index in patients with gastrointestinal cancers. J Cell Physiol. 2019;234(5):5555–5563. doi:10.1002/jcp.27373
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251–260. doi:10.1097/MCA.0000000000001117
   PubMed Web of Science ®Google Scholar
• Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens. 2004;13(2):163–170. doi:10.1097/00041552-200403000-00004
   PubMed Web of Science ®Google Scholar
• Hayiroglu MI, Cinar T, Cinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
   PubMed Web of Science ®Google Scholar
• Erdogan M, Erdol MA, Ozturk S, Durmaz T. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14(16):1553–1561. doi:10.2217/bmm-2020-0274
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;61(4):e78–e140. doi:10.1016/j.jacc.2012.11.019
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24). e139-e228. doi:10.1016/j.jacc.2014.09.017
   PubMedGoogle Scholar
• Hausenloy DJ, Chilian W, Crea F, et al. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc Res. 2019;115(7):1143–1155. doi:10.1093/cvr/cvy286
   PubMed Web of Science ®Google Scholar
• Li Q, Chen Y, Yu L, et al. The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease. Atherosclerosis. 2022;349:204–210. doi:10.1016/j.atherosclerosis.2022.04.007
   PubMedGoogle Scholar
• Washam JB, Herzog CA, Beitelshees AL, et al. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American heart association. Circulation. 2015;131(12):1123–1149. doi:10.1161/CIR.0000000000000183
   PubMedGoogle Scholar
• Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89(9):1003–1008. doi:10.1136/heart.89.9.1003
   PubMed Web of Science ®Google Scholar
• Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70(11):2021–2030. doi:10.1038/sj.ki.5001934
   PubMed Web of Science ®Google Scholar
• Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1113–1119. doi:10.1016/S0735-1097(02)01745-X
   PubMed Web of Science ®Google Scholar
• Gupta J, Mitra N, Kanetsky PA, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7(12):1938–1946. doi:10.2215/CJN.03500412
   PubMed Web of Science ®Google Scholar
• Medina-Leyte DJ, Zepeda-Garcia O, Dominguez-Perez M, Gonzalez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8):3850. doi:10.3390/ijms22083850
   PubMed Web of Science ®Google Scholar
• Kaufmanova J, Stikarova J, Hlavackova A, et al. Fibrin clot formation under oxidative stress conditions. Antioxidants. 2021;10:6. doi:10.3390/antiox10060923
   Google Scholar
• Fracassi F, Crea F, Sugiyama T, et al. Healed culprit plaques in patients with acute coronary syndromes. J Am Coll Cardiol. 2019;73(18):2253–2263. doi:10.1016/j.jacc.2018.10.093
   PubMed Web of Science ®Google Scholar
• Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol. 2014;9:73–102. doi:10.1146/annurev-pathol-020712-163936
   PubMed Web of Science ®Google Scholar
• Meyer-Lindemann U, Mauersberger C, Schmidt AC, et al. Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation. Front Immunol. 2022;13:898690.
   PubMedGoogle Scholar
• Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519–531. doi:10.1038/nri3024
   PubMed Web of Science ®Google Scholar
• Van Avondt K, Maegdefessel L, Soehnlein O. Therapeutic targeting of neutrophil extracellular traps in atherogenic inflammation. Thromb Haemost. 2019;119(4):542–552. doi:10.1055/s-0039-1678664
   PubMedGoogle Scholar
• Ikeda U, Ikeda M, Oohara T, Kano S, Yaginuma T. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis. 1990;84(2–3):183–188. doi:10.1016/0021-9150(90)90089-2
   PubMedGoogle Scholar
• Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju124
   PubMedGoogle Scholar
• Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association of neutrophil-to-lymphocyte ratio with mortality and cardiovascular disease in the Jackson heart study and modification by the Duffy antigen variant. JAMA Cardiology. 2018;3(6):455–462. doi:10.1001/jamacardio.2018.1042
   PubMedGoogle Scholar
• Guo TM, Cheng B, Ke L, et al. Prognostic value of neutrophil to lymphocyte ratio for in-hospital mortality in elderly patients with acute myocardial infarction. Curr Med Sci. 2018;38(2):354–359. doi:10.1007/s11596-018-1887-0
   PubMed Web of Science ®Google Scholar
• Li X, Ji Y, Kang J, Fang N. Association between blood neutrophil-to-lymphocyte ratio and severity of coronary artery disease: evidence from 17 observational studies involving 7017 cases. Medicine. 2018;97(39):e12432. doi:10.1097/MD.0000000000012432
   PubMed Web of Science ®Google Scholar
• Park JS, Seo KW, Choi BJ, et al. Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction. Medicine. 2018;97(48):e13471. doi:10.1097/MD.0000000000013471
   PubMed Web of Science ®Google Scholar
• Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657. doi:10.1016/j.amjcard.2008.05.006
   PubMed Web of Science ®Google Scholar
• Zhang S, Diao J, Qi C, et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):75. doi:10.1186/s12872-018-0812-6
   PubMed Web of Science ®Google Scholar
• Arbel Y, Shacham Y, Ziv-Baran T, et al. Higher neutrophil/lymphocyte ratio is related to lower ejection fraction and higher long-term all-cause mortality in ST-elevation myocardial infarction patients. Can J Cardiol. 2014;30(10):1177–1182. doi:10.1016/j.cjca.2014.05.010
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang S, Yi Y, et al. Neutrophil-to-lymphocyte ratio as a predictor for cardiovascular diseases: a cohort study in Tianjin, China. J Hum Hypertens. 2022. doi:10.1038/s41371-022-00724-7
   Google Scholar
• Schrottmaier WC, Mussbacher M, Salzmann M, Assinger A. Platelet-leukocyte interplay during vascular disease. Atherosclerosis. 2020;307:109–120. doi:10.1016/j.atherosclerosis.2020.04.018
   PubMed Web of Science ®Google Scholar
• Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res. 2008;78(1):8–17. doi:10.1093/cvr/cvn015
   PubMedGoogle Scholar
• Nikolsky E, Grines CL, Cox DA, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the Cadillac trial). Am J Cardiol. 2007;99(8):1055–1061. doi:10.1016/j.amjcard.2006.11.066
   PubMedGoogle Scholar
• Kurtul A, Yarlioglues M, Murat SN, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(3):342–347. doi:10.1016/j.amjcard.2014.04.045
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566. doi:10.1038/s41598-018-28646-w
   PubMed Web of Science ®Google Scholar
• Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol. 2020;18(1):197. doi:10.1186/s12957-020-01974-w
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715–720. doi:10.1097/MCA.0000000000001037
   PubMed Web of Science ®Google Scholar
• Candemir M, Kiziltunc E, Nurkoc S, Sahinarslan A. Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
   PubMed Web of Science ®Google Scholar
• Esenboga K, Kurtul A, Yamanturk YY, Tan TS, Tutar DE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77(1):59–65. doi:10.1080/00015385.2021.1884786
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcik D, et al. Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-ST segment elevation myocardial infarction. Angiology. 2021;72(9):889–895. doi:10.1177/00033197211007738
   PubMed Web of Science ®Google Scholar